Psychedelic Business News Spotlight: March 5, 2021
This week in psychedelic business news: two companies enter the Canadian Stock Exchange, AI comes to psychedelic treatment, and psilocybin comes to Brazil.
Entries by
Psychedelic Biotech Company Atai Life Sciences Valued At $2 Billion
Biotech company Atai Life Sciences has earned a $2 billion valuation for its work in developing psychedelic treatments for mental health issues.
Michael Pollan Explores More Psychedelics In New Book: This Is Your Mind on Plants
New York Times bestselling author Michael Pollan explores mescaline, opium, and caffeine in his forthcoming book “This Is Your Mind on Plants”.
Former UFC Fighter Ian McCall’s Reeducation on Psychedelics Comes With a Puppet Show
It’s been nearly 3 years since Ian McCall stopped UFC fighting. Now, he’s bringing psychedelics mainstream with the help of puppets.
Psychedelic Business News Spotlight: February 26, 2021
This week in psychedelic business news, Field Trip upsizes its bought deal, psilocybin truffles head to Brazil, another company goes public, and more.
‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU
NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.
Psychedelic Business News Spotlight: February 19, 2021
This week in psychedelic business news: MindMed acquires a digital health company, Mindest Pharma goes public, new MDMA treatment for PTSD, and more.
Psychedelic Business News Spotlight: February 12, 2021
This week in Psychedelic business news: MindMed has a new partner, Mydecine closes a funding round, and the world’s first legal psilocybin cultivation facility launches.
Study: 69% of Suicidal Patients Saw ‘Significant’ Improvement With Ketamine Therapy
A new study links ketamine therapy to a significant reduction in thoughts of suicide for 69 percent of study participants.
Psychedelic Business News Spotlight: February 5, 2021
This week in psychedelic business news, Super Mario’s magic mushroom gets a new use, Mindset files three patents, Bright Minds goes public, and more.
